FCFS
FirstCash Holdings, Inc
FCFS's fundamentals are mixed: revenue grew 23%, while its operating margin rose 1 points to 13%. At 20x earnings, it's trading below its usual 22x. Analysts expect strong earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
FCFS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
FCFS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FCFS.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
FCFS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $182 | — |
| Cheap | 19x | $176 | -2.9% |
| Current | 20x | $182 | — |
| Fair | 22x | $204 | +12% |
| Expensive | 26x | $240 | +32% |
Historical ranges are pointers, not guarantees.
FCFS's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
FCFS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
FCFS has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
FCFS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.21 | +32% |
| Q3 2026 | $9.23 | +33% |
| Q2 2026 | $8.76 | +35% |
| Q1 2026 | $7.98 | +28% |
| Q4 2025 | $7.42 | +29% |
| Q3 2025 | $6.93 | +28% |
| Q2 2025 | $6.51 | +25% |
| Q1 2025 | $6.25 | +22% |
| Q4 2024 | $5.73 | +19% |
FCFS has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
FCFS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +18% |
| Q2 2026 | $1.1B | +29% |
| Q1 2026 | $1.1B | +26% |
| Q4 2025 | $1.1B | +20% |
| Q3 2025 | $935.6M | +12% |
| Q2 2025 | $830.6M | 0% |
| Q1 2025 | $836.4M | 0% |
| Q4 2024 | $883.8M | +3.7% |
FCFS's revenue has grown year over year for five quarters in a row: $1.1B last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +0.6 points |
| Q2 2026 | 12% | +2.1 points |
| Q1 2026 | 14% | +0.5 points |
| Q4 2025 | 13% | +1.1 points |
| Q3 2025 | 12% | +1.8 points |
| Q2 2025 | 9.8% | +1.8 points |
| Q1 2025 | 13% | +3.5 points |
| Q4 2024 | 12% | +1.7 points |
FCFS has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
FCFS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $142M | +4.6% |
| Q2 2026 | $176.8M | +51% |
| Q1 2026 | $153.6M | +21% |
| Q3 2025 | $135.8M | +20% |
| Q2 2025 | $116.9M | +10% |
| Q1 2025 | $126.6M | +3.4% |
| Q3 2024 | $113.1M | +1.5% |
| Q2 2024 | $106.2M | +12% |
FCFS's free cash flow was $608M over the past year, up 31% from the year before. Free cash flow isn't a meaningful measure for financial services companies like FCFS.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
FCFS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -701K shares |
| 1 year | -2.6% | -1.1M shares |
| 3 years | -4.5% | -2M shares |
| 5 years | +7% | +2.8M shares |
| Available history | +1.3% | +575K shares |
FCFS has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $134.2M |
| Q2 2026 | $66.9M |
| Q1 2026 | $50M |
| Q4 2025 | $25.4M |
| Q3 2025 | $30M |
| Q2 2025 | $850,000 |
| Q1 2025 | $59.6M |
| Q4 2024 | — |
FCFS spent $277M buying back its own shares over the past year, about three times what it spent the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
FCFS Net Leverage
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
FCFS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.3 | Neutral |
| Stochastic | 16.4 | Oversold |
FCFS's weekly RSI is 39 (neutral) and its Stochastic is 16 (oversold).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
FCFS PE vs Financial Services Sector
| Metric | FCFS | Sector median | Relative |
|---|---|---|---|
| PE | 20x | 13x | 51% above |
| PE % | 21 | 63 | 42 pts below |
FCFS is trading at 20x earnings, a 51% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
FCFS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $197.3 | 7.9% below |
| 20 week MA | $208.3 | 13% below |
| 50 week MA | $199.6 | 9% below |
| 100 week MA | $165.4 | 9.9% above |
| 200 week MA | $135.7 | 34% above |
FCFS has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
FCFS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $80.8 | $70.1 | -13% |
| 2021 | $70.1 | $69.9 | -0.2% |
| 2022 | $69.9 | $87.9 | +26% |
| 2023 | $87.9 | $108.4 | +23% |
| 2024 | $108.4 | $103.1 | -4.9% |
| 2025 | $103.1 | $161.0 | +56% |
| 2026 YTD | $161.0 | $181.7 | +13% |
FCFS has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.